Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 68

References for PMC Articles for PubMed (Select 9784492)

1.

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.

RANDLE PJ, GARLAND PB, HALES CN, NEWSHOLME EA.

Lancet. 1963 Apr 13;1(7285):785-9. No abstract available.

PMID:
13990765
2.

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.

Carr A, Samaras K, Chisholm DJ, Cooper DA.

Lancet. 1998 Jun 20;351(9119):1881-3. Review.

PMID:
9652687
3.

The search for human obesity genes.

Comuzzie AG, Allison DB.

Science. 1998 May 29;280(5368):1374-7. Review.

PMID:
9603720
4.

Environmental contributions to the obesity epidemic.

Hill JO, Peters JC.

Science. 1998 May 29;280(5368):1371-4. Review.

PMID:
9603719
5.

Regulation of leptin promoter function by Sp1, C/EBP, and a novel factor.

Mason MM, He Y, Chen H, Quon MJ, Reitman M.

Endocrinology. 1998 Mar;139(3):1013-22.

PMID:
9492033
6.

Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha).

Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, Gonzalez FJ.

J Biol Chem. 1998 Mar 6;273(10):5678-84.

7.

A dominant-negative inhibitor of CREB reveals that it is a general mediator of stimulus-dependent transcription of c-fos.

Ahn S, Olive M, Aggarwal S, Krylov D, Ginty DD, Vinson C.

Mol Cell Biol. 1998 Feb;18(2):967-77.

8.

Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene.

Tanaka T, Yoshida N, Kishimoto T, Akira S.

EMBO J. 1997 Dec 15;16(24):7432-43.

9.

Troglitazone action is independent of adipose tissue.

Burant CF, Sreenan S, Hirano K, Tai TA, Lohmiller J, Lukens J, Davidson NO, Ross S, Graves RA.

J Clin Invest. 1997 Dec 1;100(11):2900-8.

10.

Hyperleptinemia of pregnancy associated with the appearance of a circulating form of the leptin receptor.

Gavrilova O, Barr V, Marcus-Samuels B, Reitman M.

J Biol Chem. 1997 Nov 28;272(48):30546-51.

11.

CAAT/enhancer binding proteins directly modulate transcription from the peroxisome proliferator-activated receptor gamma 2 promoter.

Clarke SL, Robinson CE, Gimble JM.

Biochem Biophys Res Commun. 1997 Nov 7;240(1):99-103.

PMID:
9367890
13.

A general method to design dominant negatives to B-HLHZip proteins that abolish DNA binding.

Krylov D, Kasai K, Echlin DR, Taparowsky EJ, Arnheiter H, Vinson C.

Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12274-9.

14.

Short term effects of leptin on hepatic gluconeogenesis and in vivo insulin action.

Rossetti L, Massillon D, Barzilai N, Vuguin P, Chen W, Hawkins M, Wu J, Wang J.

J Biol Chem. 1997 Oct 31;272(44):27758-63.

15.

Insulin stimulates both leptin secretion and production by rat white adipose tissue.

Barr VA, Malide D, Zarnowski MJ, Taylor SI, Cushman SW.

Endocrinology. 1997 Oct;138(10):4463-72.

PMID:
9322964
16.

Acute stimulation of glucose metabolism in mice by leptin treatment.

Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ.

Nature. 1997 Sep 25;389(6649):374-7.

PMID:
9311777
17.

Transcriptional regulatory region for expression of the rat ATP citrate-lyase gene.

Fukuda H, Iritani N, Noguchi T.

Eur J Biochem. 1997 Jul 15;247(2):497-502.

18.

A dominant negative to activation protein-1 (AP1) that abolishes DNA binding and inhibits oncogenesis.

Olive M, Krylov D, Echlin DR, Gardner K, Taparowsky E, Vinson C.

J Biol Chem. 1997 Jul 25;272(30):18586-94.

19.

Transcriptional regulatory regions for expression of the rat fatty acid synthase.

Fukuda H, Iritani N, Noguchi T.

FEBS Lett. 1997 Apr 14;406(3):243-8.

20.

Leptin expression and action: new experimental paradigms.

Flier JS.

Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4242-5. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk